Results of Randomized Study Evaluating the Safety and Efficacy of Cenobamate in Patients with Uncontrolled Focal-Onset Epilepsy Published in The Lancet Neurology

Ads

You May Also Like

ArQule to Report Fourth Quarter and Full Year 2015 Financial Results on February 29, 2016

BURLINGTON, Mass., Feb. 15, 2016 (GLOBE NEWSWIRE) -- ArQule, Inc. (NASDAQ:ARQL) today announced it ...

Sandoz receives US FDA approval for biosimilar Hyrimoz(TM) (adalimumab-adaz)

Biosimilar HyrimozTM (adalimumab-adaz) approved for all indications of reference medicine not protected by orphan ...

Deinove enters into collaboration with bioMérieux to discover new antibiotics

DEINOVE ENTERS INTO COLLABORATION WITH BIOMÉRIEUX TO DISCOVER NEW ANTIBIOTICS bioMérieux will provide DEINOVE ...